Knee Osteoarthritis Treatment Market Overview and Forecast by 2031
The Knee Osteoarthritis Treatment Market is expected to register a CAGR of 9.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
The report is segmented by Knee Osteoarthritis Treatment Market By Treatment Type (Non-Surgical Treatment, Surgical Treatment); End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Knee Osteoarthritis Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Knee Osteoarthritis Treatment Market Segmentation
By Treatment Type- Non-Surgical Treatment
- Surgical Treatment
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Strategic Insights
Knee Osteoarthritis Treatment Market Growth Drivers- Rising Prevalence of Knee Osteoarthritis: One of the main causes is the rising prevalence of knee osteoarthritis (KOA), especially in the elderly population. The number of people with KOA is predicted to increase dramatically as the world's population ages, increasing the need for available treatment alternatives.
- Aging Population: Another important aspect affecting market growth is an aging population. The need for knee osteoarthritis (KOA) treatment that can deliver potential treatment option precisely and safely over long periods of time is increased by the fact that older persons often need specialized care and long-term medication administration.
- Advanced Solutions: For KOA patients, the use of digital health technologies like wearable technology and smartphone apps is improving illness management. Real-time monitoring of symptoms and activity levels is made possible by these technologies, which enhances patient participation and makes customized treatment programs possible. Access to healthcare services has also been made easier by telemedicine, which has grown in significance, particularly since COVID-19.
- Technological Advancements: The management of KOA is changing as a result of the introduction of novel therapies, including as biologics and disease-modifying osteoarthritis medications (DMOADs). Because of their ability to restore damaged cartilage and lower inflammation, therapies like stem cell treatments, platelet-rich plasma (PRP) injections, and hyaluronic acid injections are becoming more popular. Both patients and healthcare professionals looking for better solutions find these developments appealing.
- Increased Investment in Research and Development: R&D for novel treatments that target KOA is becoming more and more important. Pharmaceutical firms are making significant investments in creating innovative therapeutic approaches that target osteoarthritis's underlying causes as well as its symptoms. This includes continuing research and clinical trials to find novel biologic treatments.
- Growing Awareness and Education: The need for efficient therapies is being driven by patients' and healthcare professionals' growing knowledge of knee osteoarthritis. More people are seeking medical attention early because to educational programs designed to increase awareness of KOA symptoms and available treatments. Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Favorable Regulatory Environment: New medicines that target KOA are being approved more quickly thanks to supportive regulatory regimes, especially in North America and Europe. A dedication to meeting unmet medical needs in this field is demonstrated by the FDA's fast-track designation for specific medicines.The market for knee osteoarthritis is expanding as a result of rising healthcare costs worldwide. Growing disposable incomes across different regions also assist patients' increased willingness to spend money on cutting-edge treatments that promise greater results.
- Wearable Devices: Wearable technology, including activity trackers and smartwatches, makes it possible to measure joint movement, gait, and levels of physical activity in real time. When necessary, early intervention can be facilitated by using the useful data these devices give to help healthcare providers customize treatment programs based on patient activity patterns and symptom changes.
- Potential for New Treatment Paradigms: With features like medication reminders, symptom tracking, and KOA education materials, mobile applications enable patients to better manage their disease. By allowing patients to log their symptoms and monitor their progress, these apps improve self-management and may result in increased participation in treatment regimens.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Knee Osteoarthritis Treatment Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Knee Osteoarthritis Treatment Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
High Competition and Price Pressure
Europe region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period
Asia Pacific region is expected to witness the highest growth during the forecast period
Rising Prevalence of Knee Osteoarthritis
The Knee Osteoarthritis Treatment Market is estimated to witness a CAGR of 9.5% from 2023 to 2031
Favorable Regulatory Environment
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Knee Osteoarthritis Treatment Market - By Treatment Type
1.3.2 Knee Osteoarthritis Treatment Market - By End-user
1.3.3 Knee Osteoarthritis Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. KNEE OSTEOARTHRITIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. KNEE OSTEOARTHRITIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. KNEE OSTEOARTHRITIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. KNEE OSTEOARTHRITIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. KNEE OSTEOARTHRITIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. KNEE OSTEOARTHRITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON-SURGICAL TREATMENT
7.3.1. Overview
7.3.2. Non-Surgical Treatment Market Forecast and Analysis
7.3.3. Drugs Market
7.3.3.1. Overview
7.3.3.2. Drugs Market Forecast and Analysis
7.3.4. Alternate Therapies Market
7.3.4.1. Overview
7.3.4.2. Alternate Therapies Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. SURGICAL TREATMENT
7.4.1. Overview
7.4.2. Surgical Treatment Market Forecast and Analysis
8. KNEE OSTEOARTHRITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. SPECIALTY CLINICS
8.5.1. Overview
8.5.2. Specialty Clinics Market Forecast and Analysis
9. KNEE OSTEOARTHRITIS TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Knee Osteoarthritis Treatment Market Overview
9.1.2 North America Knee Osteoarthritis Treatment Market Forecasts and Analysis
9.1.3 North America Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Knee Osteoarthritis Treatment Market Forecasts and Analysis - By End-user
9.1.5 North America Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Knee Osteoarthritis Treatment Market
9.1.5.1.1 Canada Knee Osteoarthritis Treatment Market by Treatment Type
9.1.5.1.2 Canada Knee Osteoarthritis Treatment Market by End-user
9.1.5.2 Mexico Knee Osteoarthritis Treatment Market
9.1.5.2.1 Mexico Knee Osteoarthritis Treatment Market by Treatment Type
9.1.5.2.2 Mexico Knee Osteoarthritis Treatment Market by End-user
9.1.5.3 US Knee Osteoarthritis Treatment Market
9.1.5.3.1 US Knee Osteoarthritis Treatment Market by Treatment Type
9.1.5.3.2 US Knee Osteoarthritis Treatment Market by End-user
9.2. EUROPE
9.2.1 Europe Knee Osteoarthritis Treatment Market Overview
9.2.2 Europe Knee Osteoarthritis Treatment Market Forecasts and Analysis
9.2.3 Europe Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Knee Osteoarthritis Treatment Market Forecasts and Analysis - By End-user
9.2.5 Europe Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Knee Osteoarthritis Treatment Market
9.2.5.1.1 Germany Knee Osteoarthritis Treatment Market by Treatment Type
9.2.5.1.2 Germany Knee Osteoarthritis Treatment Market by End-user
9.2.5.2 France Knee Osteoarthritis Treatment Market
9.2.5.2.1 France Knee Osteoarthritis Treatment Market by Treatment Type
9.2.5.2.2 France Knee Osteoarthritis Treatment Market by End-user
9.2.5.3 Italy Knee Osteoarthritis Treatment Market
9.2.5.3.1 Italy Knee Osteoarthritis Treatment Market by Treatment Type
9.2.5.3.2 Italy Knee Osteoarthritis Treatment Market by End-user
9.2.5.4 Spain Knee Osteoarthritis Treatment Market
9.2.5.4.1 Spain Knee Osteoarthritis Treatment Market by Treatment Type
9.2.5.4.2 Spain Knee Osteoarthritis Treatment Market by End-user
9.2.5.5 United Kingdom Knee Osteoarthritis Treatment Market
9.2.5.5.1 United Kingdom Knee Osteoarthritis Treatment Market by Treatment Type
9.2.5.5.2 United Kingdom Knee Osteoarthritis Treatment Market by End-user
9.2.5.6 Rest of Europe Knee Osteoarthritis Treatment Market
9.2.5.6.1 Rest of Europe Knee Osteoarthritis Treatment Market by Treatment Type
9.2.5.6.2 Rest of Europe Knee Osteoarthritis Treatment Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Knee Osteoarthritis Treatment Market Overview
9.3.2 Asia-Pacific Knee Osteoarthritis Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Knee Osteoarthritis Treatment Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Knee Osteoarthritis Treatment Market
9.3.5.1.1 Australia Knee Osteoarthritis Treatment Market by Treatment Type
9.3.5.1.2 Australia Knee Osteoarthritis Treatment Market by End-user
9.3.5.2 China Knee Osteoarthritis Treatment Market
9.3.5.2.1 China Knee Osteoarthritis Treatment Market by Treatment Type
9.3.5.2.2 China Knee Osteoarthritis Treatment Market by End-user
9.3.5.3 India Knee Osteoarthritis Treatment Market
9.3.5.3.1 India Knee Osteoarthritis Treatment Market by Treatment Type
9.3.5.3.2 India Knee Osteoarthritis Treatment Market by End-user
9.3.5.4 Japan Knee Osteoarthritis Treatment Market
9.3.5.4.1 Japan Knee Osteoarthritis Treatment Market by Treatment Type
9.3.5.4.2 Japan Knee Osteoarthritis Treatment Market by End-user
9.3.5.5 South Korea Knee Osteoarthritis Treatment Market
9.3.5.5.1 South Korea Knee Osteoarthritis Treatment Market by Treatment Type
9.3.5.5.2 South Korea Knee Osteoarthritis Treatment Market by End-user
9.3.5.6 Rest of Asia-Pacific Knee Osteoarthritis Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Knee Osteoarthritis Treatment Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Knee Osteoarthritis Treatment Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Knee Osteoarthritis Treatment Market Overview
9.4.2 Middle East and Africa Knee Osteoarthritis Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Knee Osteoarthritis Treatment Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Knee Osteoarthritis Treatment Market
9.4.5.1.1 South Africa Knee Osteoarthritis Treatment Market by Treatment Type
9.4.5.1.2 South Africa Knee Osteoarthritis Treatment Market by End-user
9.4.5.2 Saudi Arabia Knee Osteoarthritis Treatment Market
9.4.5.2.1 Saudi Arabia Knee Osteoarthritis Treatment Market by Treatment Type
9.4.5.2.2 Saudi Arabia Knee Osteoarthritis Treatment Market by End-user
9.4.5.3 U.A.E Knee Osteoarthritis Treatment Market
9.4.5.3.1 U.A.E Knee Osteoarthritis Treatment Market by Treatment Type
9.4.5.3.2 U.A.E Knee Osteoarthritis Treatment Market by End-user
9.4.5.4 Rest of Middle East and Africa Knee Osteoarthritis Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Knee Osteoarthritis Treatment Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Knee Osteoarthritis Treatment Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Knee Osteoarthritis Treatment Market Overview
9.5.2 South and Central America Knee Osteoarthritis Treatment Market Forecasts and Analysis
9.5.3 South and Central America Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Knee Osteoarthritis Treatment Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Knee Osteoarthritis Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Knee Osteoarthritis Treatment Market
9.5.5.1.1 Brazil Knee Osteoarthritis Treatment Market by Treatment Type
9.5.5.1.2 Brazil Knee Osteoarthritis Treatment Market by End-user
9.5.5.2 Argentina Knee Osteoarthritis Treatment Market
9.5.5.2.1 Argentina Knee Osteoarthritis Treatment Market by Treatment Type
9.5.5.2.2 Argentina Knee Osteoarthritis Treatment Market by End-user
9.5.5.3 Rest of South and Central America Knee Osteoarthritis Treatment Market
9.5.5.3.1 Rest of South and Central America Knee Osteoarthritis Treatment Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Knee Osteoarthritis Treatment Market by End-user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. KNEE OSTEOARTHRITIS TREATMENT MARKET, KEY COMPANY PROFILES
11.1. AVM BIOTECHNOLOGY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BIOVENTUS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FLEXION THERAPEUTICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ANIKA THERAPEUTICS, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ORTHOTROPHIX, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ZIMMER BIOMET
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GLAXOSMITHKLINE PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI SA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. AVM Biotechnology
2. Bioventus
3. Flexion Therapeutics
4. Anika Therapeutics, Inc
5. OrthoTrophix, Inc.
6. Pfizer Inc.
7. Zimmer Biomet
8. Novartis AG
9. GlaxoSmithKline plc
10. Sanofi SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For